Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Daily News

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

L.A. McKeown

April 22, 2021

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

L.A. McKeown

June 10, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

L.A. McKeown

February 20, 2019

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

L.A. McKeown

February 19, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Daily News

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

L.A. McKeown

December 20, 2016

News Daily News

Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD

Todd Neale

September 13, 2016

News Daily News

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Caitlin E. Cox

May 29, 2015

News Daily News

ISET Abstracts Shed Light on Novel Therapies for PAD

Caitlin E. Cox

February 04, 2015

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Daily News

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

May 30, 2014

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Daily News

双组研究结果支持利用紫杉醇方法治疗股腘动脉病

Caitlin E. Cox

April 05, 2013

News Daily News

Pair of Studies Support Paclitaxel-Eluting Devices for Treating Femoropopliteal Disease

Caitlin E. Cox

April 05, 2013

News Daily News

2 Estudios Avalan el Uso de Dispositivos liberadores de Paclitaxel en el Tratamiento de la Enfermedad Femoropoplítea

Caitlin E. Cox

April 05, 2013

Advertisement

Top Endovascular News of 2022

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Vascular Experts Say It’s Time to Let Paclitaxel Out of Regulatory Jail

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

TCTMD’s Top 10 Most Popular Stories for February 2019

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

Drug-Coated Balloon Gets Expanded Indication for In-Stent Restenosis in PAD

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

ISET Abstracts Shed Light on Novel Therapies for PAD

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

双组研究结果支持利用紫杉醇方法治疗股腘动脉病

Pair of Studies Support Paclitaxel-Eluting Devices for Treating Femoropopliteal Disease

2 Estudios Avalan el Uso de Dispositivos liberadores de Paclitaxel en el Tratamiento de la Enfermedad Femoropoplítea

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content